Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Yates

Showing results (601-610 of 660) with videos related to

Pageof 66
Sort By:
Drug Safety|February 12, 2017
Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed CohortR A Charlton, A McGrogan, J Snowball, et al.
BMJ Supportive & Palliative Care|January 22, 2018
Systematic review of general practice end-of-life symptom controlGeoffrey K Mitchell, Hugh E Senior, Claire E Johnson, et al.
Thorax|May 31, 2002
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999T Djuretic, J Herbert, F Drobniewski, et al.
Journal of Medicinal Chemistry|July 26, 2011
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolinesFeng Liu, Dalia Barsyte-Lovejoy, Abdellah Allali-Hassani, et al.
American Journal of Hematology|May 31, 2020
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell diseaseAlex George, Bogdan Dinu, Norma Estrada, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 17, 2016
Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information ServicesJ L Richardson, S Stephens, L M Yates, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1996
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosisN Kennedy, L Berger, J Curram, et al.
Disease Models & Mechanisms|October 12, 2018
17-DMAG regulates p21 expression to induce chondrogenesis <i>in vitro</i> and <i>in vivo</i>Karri L Bertram, Nadia Narendran, Pankaj Tailor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 3, 2026
Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unitKimberly E Alexander, Theodora Ogle, Brighid Scanlon, et al.
Epilepsia|June 25, 2026
Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long-term health and well-being: A contribution from the ConcePTION projectP A Wells, J L Richardson, D Astill, et al.
Pageof 66

Showing results (601-610 of 660) with videos related to

Sort By:
Pageof 66
Drug Safety|February 12, 2017
Sensitivity of the UK Clinical Practice Research Datalink to Detect Neurodevelopmental Effects of Medicine Exposure in Utero: Comparative Analysis of an Antiepileptic Drug-Exposed CohortR A Charlton, A McGrogan, J Snowball, et al.
BMJ Supportive & Palliative Care|January 22, 2018
Systematic review of general practice end-of-life symptom controlGeoffrey K Mitchell, Hugh E Senior, Claire E Johnson, et al.
Thorax|May 31, 2002
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999T Djuretic, J Herbert, F Drobniewski, et al.
Journal of Medicinal Chemistry|July 26, 2011
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolinesFeng Liu, Dalia Barsyte-Lovejoy, Abdellah Allali-Hassani, et al.
American Journal of Hematology|May 31, 2020
Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell diseaseAlex George, Bogdan Dinu, Norma Estrada, et al.
Reproductive Toxicology (Elmsford, N.Y.)|November 17, 2016
Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information ServicesJ L Richardson, S Stephens, L M Yates, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1996
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosisN Kennedy, L Berger, J Curram, et al.
Disease Models & Mechanisms|October 12, 2018
17-DMAG regulates p21 expression to induce chondrogenesis <i>in vitro</i> and <i>in vivo</i>Karri L Bertram, Nadia Narendran, Pankaj Tailor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 3, 2026
Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unitKimberly E Alexander, Theodora Ogle, Brighid Scanlon, et al.
Epilepsia|June 25, 2026
Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long-term health and well-being: A contribution from the ConcePTION projectP A Wells, J L Richardson, D Astill, et al.
Pageof 66